SHL — Sonic Healthcare Share Price
- AU$12.19bn
- AU$16.59bn
- AU$8.97bn
- 87
- 64
- 81
- 89
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 20.34 | ||
PEG Ratio (f) | 1.53 | ||
EPS Growth (f) | 15.29% | ||
Dividend Yield (f) | 4.38% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.49 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 17.02 | ||
Price to Sales | 1.31 | ||
EV to EBITDA | 9.48 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 7.24% | ||
Return on Equity | 6.86% | ||
Operating Margin | 10.21% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 6,831.84 | 8,754.12 | 9,340.15 | 8,168.95 | 8,967.41 | 9,665.32 | 10,562.79 | 7.89% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -6.04 | +141.69 | +10.57 | -52.1 | -28.32 | +4.97 | +17.58 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sonic Healthcare Limited is an Australia-based healthcare provider. The Company is engaged in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. The Company operates through three segments: Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Radiology technologies include Magnetic resonance imaging (MRI), Computed tomography (CT), Ultrasound, X-ray, Mammography, and others. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The Company's provides services to clinicians, hospitals, community health services, and their patients. The Company has more than 120 radiology centers.
Directors
- Mark Compton NEC (60)
- Colin Goldschmidt CEO (67)
- Christopher Wilks CFO (63)
- Paul Alexander SEC
- Philip Dubois NED (75)
- Suzanne Crowe NID (70)
- Neville Mitchell NID (62)
- Louis Panaccio NID (64)
- Kathryn Spargo NID (69)
- Elizabeth Wilson NID (63)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 25th, 1934
- Public Since
- September 25th, 1934
- No. of Shareholders
- 95,737
- No. of Employees
- 42,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 480,215,619

- Address
- Level 22, 225 George Street, SYDNEY, 2000
- Web
- https://www.sonichealthcare.com/
- Phone
- +61 298555444
- Auditors
- PricewaterhouseCoopers
Upcoming Events for SHL
Similar to SHL
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Careteq
Australian Stock Exchange - SEATS
FAQ
As of Today at 23:21 UTC, shares in Sonic Healthcare are trading at AU$25.38. This share price information is delayed by 15 minutes.
Shares in Sonic Healthcare last closed at AU$25.38 and the price had moved by -2.35% over the past 365 days. In terms of relative price strength the Sonic Healthcare share price has underperformed the ASX All Ordinaries Index by -3.81% over the past year.
The overall consensus recommendation for Sonic Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Sonic Healthcare dividend yield is 4.22% based on the trailing twelve month period.
Last year, Sonic Healthcare paid a total dividend of AU$1.07, and it currently has a trailing dividend yield of 4.22%. We do not have any data on when Sonic Healthcare is to next pay dividends.
We do not have data on when Sonic Healthcare is to next pay dividends. The historic dividend yield on Sonic Healthcare shares is currently 4.22%.
To buy shares in Sonic Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$25.38, shares in Sonic Healthcare had a market capitalisation of AU$12.19bn.
Here are the trading details for Sonic Healthcare:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: SHL
Based on an overall assessment of its quality, value and momentum Sonic Healthcare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Sonic Healthcare is AU$29.01. That is 14.3% above the last closing price of AU$25.38.
Analysts covering Sonic Healthcare currently have a consensus Earnings Per Share (EPS) forecast of AU$1.09 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sonic Healthcare. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -0.93%.
As of the last closing price of AU$25.38, shares in Sonic Healthcare were trading -6.8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sonic Healthcare PE ratio based on its reported earnings over the past 12 months is 20.34. The shares last closed at AU$25.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sonic Healthcare's management team is headed by:
- Mark Compton - NEC
- Colin Goldschmidt - CEO
- Christopher Wilks - CFO
- Paul Alexander - SEC
- Philip Dubois - NED
- Suzanne Crowe - NID
- Neville Mitchell - NID
- Louis Panaccio - NID
- Kathryn Spargo - NID
- Elizabeth Wilson - NID